Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $32
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Glen Santangelo maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $30 to $32.
Barclays analyst Glen Santangelo maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from $30 to $32.
